PRESS RELEASE: Important research collaboration for pioneering PRS approach OXFORD, England & MANCHESTER, England–(BUSINESS WIRE)–May 22, 2018– Cytox, a precision medicine front-runner which today is commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developing Alzheimer’s and other ne…Read More